Literature DB >> 34357399

SARS-CoV-2 Antibody Responses in Infection-Naive or Previously Infected Individuals After 1 and 2 Doses of the BNT162b2 Vaccine.

Mark Anderson1, Michael Stec1, Ayesan Rewane2, Alan Landay2, Gavin Cloherty1, James Moy2.   

Abstract

Entities:  

Year:  2021        PMID： 34357399     DOI： 10.1001/jamanetworkopen.2021.19741

Source DB:  PubMed          Journal:  JAMA Netw Open        ISSN： 2574-3805


× No keyword cloud information.
  11 in total

1.  Effectiveness and protection duration of Covid-19 vaccines and previous infection against any SARS-CoV-2 infection in young adults.

Authors:  Lior Rennert; Zichen Ma; Christopher S McMahan; Delphine Dean
Journal:  Nat Commun       Date:  2022-07-08       Impact factor: 17.694

2.  Post-vaccination analysis of anti-spike antibody responses in kidney transplant recipients with and without COVID-19 infection in a tertiary care centre, India.

Authors:  Sanjiv Jasuja; Vivekanand Jha; Gaurav Sagar; Anupam Bahl; Shalini Verma; Neharita Jasuja; Jasmeet Kaur
Journal:  Clin Kidney J       Date:  2022-03-03

3.  SARS-CoV-2-neutralizing humoral IgA response occurs earlier but modest and diminishes faster compared to IgG response.

Authors:  Yuki Takamatsu; Kazumi Omata; Yosuke Shimizu; Noriko Kinoshita-Iwamoto; Mari Terada; Tetsuya Suzuki; Shinichiro Morioka; Yukari Uemura; Norio Ohmagari; Kenji Maeda; Hiroaki Mitsuya
Journal:  bioRxiv       Date:  2022-06-09

4.  Vaccination of COVID-19 convalescent plasma donors increases binding and neutralizing antibodies against SARS-CoV-2 variants.

Authors:  Clara Di Germanio; Graham Simmons; Chloe Thorbrogger; Rachel Martinelli; Mars Stone; Thomas Gniadek; Michael P Busch
Journal:  Transfusion       Date:  2022-02-13       Impact factor: 3.337

5.  Humoral immunogenicity and tolerability of heterologous ChAd/BNT compared with homologous BNT/BNT and ChAd/ChAd SARS-CoV-2 vaccination in hemodialysis patients : A multicenter prospective observational study.

Authors:  Michael Haase; Paul Lesny; Mark Anderson; Gavin Cloherty; Michael Stec; Anja Haase-Fielitz; Mathias Haarhaus; Carla Santos-Araújo; Pedro Mota Veiga; Fernando Macario
Journal:  J Nephrol       Date:  2022-01-27       Impact factor: 4.393

6.  SARS-CoV-2 vaccine antibody response and breakthrough infection in dialysis.

Authors:  Shuchi Anand; Maria E Montez-Rath; Jialin Han; Pablo Garcia; LinaCel Cadden; Patti Hunsader; Curt Morgan; Russell Kerschmann; Paul Beyer; Mary Dittrich; Geoffrey A Block; Glenn M Chertow; Julie Parsonnet
Journal:  medRxiv       Date:  2021-10-14

7.  SARS-CoV-2 neutralizing antibodies after one or two doses of Comirnaty (BNT162b2, BioNTech/Pfizer): Kinetics and comparison with chemiluminescent assays.

Authors:  Andrea Padoan; Chiara Cosma; Francesco Bonfante; Foscarina Della Rocca; Francesco Barbaro; Claudia Santarossa; Luigi Dall'Olmo; Matteo Pagliari; Alessio Bortolami; Annamaria Cattelan; Vito Cianci; Daniela Basso; Mario Plebani
Journal:  Clin Chim Acta       Date:  2021-10-28       Impact factor: 3.786

8.  SARS-CoV-2 Receptor-Binding Domain IgG Response to AstraZeneca AZD1222 COVID-19 Vaccination, Jamaica.

Authors:  Ynolde E Leys; Magdalene Nwokocha; Jerome P Walker; Tiffany R Butterfield; Velesha D Frater; Tamara K Thompson; Mark Anderson; Gavin A Cloherty; Joshua J Anzinger
Journal:  Am J Trop Med Hyg       Date:  2022-03-23       Impact factor: 3.707

9.  mRNA vaccine-a desirable therapeutic strategy for surmounting COVID-19 pandemic.

Authors:  Peixian Chen; Xiaoye Shi; Weixin He; Guowei Zhong; Yan Tang; Hailin Wang; Peidong Zhang
Journal:  Hum Vaccin Immunother       Date:  2022-03-23       Impact factor: 3.452

10.  Durability of Humoral Responses after the Second Dose of mRNA BNT162b2 Vaccine in Residents of a Long Term Care Facility.

Authors:  Alessia Lai; Barbara Caimi; Marco Franzetti; Annalisa Bergna; Rossella Velleca; Antonella Gatti; Pier Luigi Rossi; Marco D'Orso; Fabrizio Pregliasco; Claudia Balotta; Giuseppe Calicchio
Journal:  Vaccines (Basel)       Date:  2022-03-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.